Torcetrapib – others are asking the same questions I am


Forbes has the scoop. This stuff doesn’t just come out of thin air, as we learned with the Vioxx situation. There are warning signs. Kindler had to know about this when he was standing in front of investors saying that torcetrapib was going to save their pipeline, or whatever.

Also, the lawsuit.

For the latest in torcetrapib news, glue your eyes to Pharmagossip.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: